Pull to refresh
Logo
Daily Brief
Following
Why
Neuralink

Neuralink

Neurotechnology Company

Appears in 2 stories

Stories

Neuralink's human brain-computer interface trials

New Capabilities

Brain-computer interface company developing implantable devices to restore function in people with paralysis and, eventually, augment human cognition. - Conducting multinational clinical trials

Two years ago, Neuralink implanted a coin-sized chip in Noland Arbaugh's brain—the first human to receive the company's Telepathy device. As of January 28, 2026, twenty-one people across four countries are using Neuralink implants to control computers, phones, and robotic arms with their thoughts. Several participants now exceed the cursor-control speed of able-bodied people using a mouse.

Updated Feb 2

The race to restore sight

New Capabilities

Brain-computer interface company developing Blindsight, a cortical implant that bypasses the eye to restore vision. - Developing Blindsight cortical visual prosthesis, FDA breakthrough designation received

Stanford researchers implanted a chip smaller than a Tic Tac under the retinas of 38 blind patients. A year later, 27 could read again. Some read entire books. The PRIMA device, published October 20, 2025 in the New England Journal of Medicine, is the first prosthetic to restore functional vision to people with macular degeneration—the leading cause of irreversible blindness.

Updated Jan 9